Your browser doesn't support javascript.
loading
Pharmacokinetics of Flunarizine Hydrochloride After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.
Xu, Yan-Ying; Yi, Zhi-Heng; Li, Xiao-Min; Li, Dai; Pan, Lin; Dai, Yi-Xin; Zhong, Xue-Feng; Yan, Juan; Xu, Ping-Sheng; Xu, Su-Mei.
Affiliation
  • Xu YY; Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, Changsha, PR China.
  • Yi ZH; Hunan Dinuo Pharmaceutical Co. Ltd., Changsha, PR China.
  • Li XM; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Li D; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Pan L; Hunan Dinuo Pharmaceutical Co. Ltd., Changsha, PR China.
  • Dai YX; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Zhong XF; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Yan J; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Xu PS; Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, PR China.
  • Xu SM; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, PR China.
Clin Pharmacol Drug Dev ; 11(3): 341-347, 2022 03.
Article in En | MEDLINE | ID: mdl-34472200
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flunarizine Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Flunarizine Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Pharmacol Drug Dev Year: 2022 Document type: Article Country of publication: United States